Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,65 USD | -1,08% | -19,78% | +19,73% |
03/05 | Aileron Therapeutics sluit direct aanbod van aandelen en warrants af | MT |
01/05 | Transcript : Aileron Therapeutics, Inc. - Special Call |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 62,63 mln. 58,27 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -23 mln. -21,4 mln. | Nettowinst (verlies) 2025 * | -27 mln. -25,12 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,02
x | K/w-verhouding 2025 * |
-2,04
x | Werknemers | 15 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,91% |
Recentste transcriptie over Aileron Therapeutics, Inc.
1 dag | -1,08% | ||
1 week | -19,78% | ||
Lopende maand | -19,78% | ||
1 maand | -35,51% | ||
3 maanden | -18,25% | ||
6 maanden | +148,30% | ||
Lopend jaar | +19,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Brian Windsor
CEO | Chief Executive Officer | 57 | 31-10-23 |
Director of Finance/CFO | 48 | 01-10-23 | |
David Annis
CTO | Chief Tech/Sci/R&D Officer | 51 | 01-11-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 68 | 19-06-19 | |
Alan Musso
BRD | Director/Board Member | 62 | 31-10-23 |
Brian Windsor
CEO | Chief Executive Officer | 57 | 31-10-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
08-05-24 | 3,65 | -1,08% | 44 507 |
07-05-24 | 3,69 | -6,58% | 241 733 |
06-05-24 | 3,95 | +5,05% | 87 757 |
03-05-24 | 3,76 | -1,57% | 142 725 |
02-05-24 | 3,82 | -8,17% | 149 308 |
uitgestelde koers Nasdaq, 08 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,73% | 62,63 mln. | |
+2,93% | 106 mld. | |
+7,02% | 23,47 mld. | |
-14,60% | 21,9 mld. | |
-7,05% | 18,77 mld. | |
-38,55% | 17,85 mld. | |
-8,83% | 16,78 mld. | |
+5,51% | 14,41 mld. | |
+37,49% | 12,86 mld. | |
+329,39% | 8,78 mld. |